GTCR is joining hands with Steve Powell and Mary Mattes to launch Harpula Health, a new platform that will build and acquire tech-enabled pharmaceutical services assets, Sarah writes.
Why it matters: Many anticipated processes for tech-centric pharma services assets (like Medrio) were pushed to 2023 amid this year's unfriendly deal environment, but buyers remain eager to invest in the fragmented industry as tailwinds persist.
